CareDx to acquire cancer testing company Naveris for up to $260 million

April 28, 2026 4:05 PM

CareDx Inc. (NASDAQ: CDNA) announced a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found